# Benefits of Switching Antidepressants Following Early Nonresponse

> **NCT00519012** · PHASE4 · UNKNOWN · sponsor: **Oizumi Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Sertraline to Paroxetine
- **DRUG:** Paroxetine to Sertraline

## Key facts

- **NCT ID:** NCT00519012
- **Lead sponsor:** Oizumi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-08
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2009-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00519012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00519012, "Benefits of Switching Antidepressants Following Early Nonresponse". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00519012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*